New Stock News | Saimate Plans to List on the Hong Kong Stock Exchange. The China Securities Regulatory Commission requires additional explanations regarding specific arrangements for the split of shares.
On November 7th, the China Securities Regulatory Commission announced the "Supplementary Materials Requirements for Overseas Issuance and Listing Filing (November 3rd, 2025 - November 7th, 2025)"
On November 7th, the China Securities Regulatory Commission announced the "Supplementary Materials Requirements for Overseas Issuance and Listing Filing (November 3, 2025 - November 7, 2025)". The International Affairs Department of the China Securities Regulatory Commission disclosed the supplementary material requirements for 13 companies, including the requirement for Saimit to provide detailed plans for the stock split, and whether it would affect the number of shares to be issued in this offering. According to the disclosure on September 19th by the Hong Kong Stock Exchange, Saimit Information Group Limited (referred to as Saimit) submitted an application for listing on the main board of the Hong Kong Stock Exchange, with HAITONG INT'L, CITIC SEC, and China Securities Co., Ltd. International acting as joint sponsors.
The China Securities Regulatory Commission requested Saimit to provide clarification on the following matters, and asked lawyers to verify and provide clear legal opinions:
1. Regarding equity changes: (1) Please explain the pricing basis for the company's past capital increases and equity transfers, whether the capital has been fully paid, whether there are situations of unfulfilled capital obligations, capital diversion, or flaws in the capital contribution method; (2) Please explain whether the participants in the company's employee stock incentive plan are employees of the company, whether there are external participants, whether participants who leave the company still hold related incentive shares, whether it complies with previous agreements, whether there are disputes or potential disputes, and to provide clear conclusions on the legality and compliance of implemented stock incentive plans and post-listing stock option incentive plans.
2. Regarding shareholder situations: (1) Please explain whether there are legal entities prohibited from holding shares in domestic entities after the penetration of shareholder Wuxi Chongwei; (2) Please explain the rationale for the reasonableness of the prices of new shareholders who have entered in the last 12 months, the reasons for any differences in entry prices, whether there are abnormal considerations for entry prices, and provide clear conclusions on the existence of profit transfers.
3. Regarding business operations: (1) Please explain the specific situations of the company and its subsidiaries' business scope, including "data processing services, internet data services, value-added telecommunications services, advertising design, agency, organization of cultural and artistic exchange activities", whether they are actually conducting related business and their specific operational situations, whether necessary qualifications and licenses have been obtained, whether the business scope and actual business activities involve restricted or prohibited areas for foreign investment, and whether they continue to meet foreign investment access policy requirements before and after this listing and "full circulation"; (2) Please describe the business model and specific applications, functions, etc. involving large-scale scenarios in simple terms.
4. Regarding standardized operations: Please explain whether the company and its subsidiaries are involved in developing, operating websites, mini-programs, apps, public accounts, and other products, whether they provide information content to third parties, types of information content provided, and information content security measures; also, explain the scale of user information collection and storage, data collection and usage, arrangements or measures for personal information protection and data security before and after listing.
5. Regarding this issuance and listing and "full circulation": (1) Please explain the specific plans for the stock split, and whether it will affect the number of shares to be issued in this offering; (2) Please explain the estimated amount of funds to be raised before and after the exercise of the over-allotment option, the specific calculation method, the specific use of the raised funds, and the proportion of domestic and overseas usage, and if there are overseas investment projects involved, please explain the status of overseas investment approval, approval or filing procedures; (3) Please explain whether the shares held by the shareholders intending to participate in "full circulation" have any defects such as pledge, freeze, or other rights.
According to the prospectus, Saimit is a leading provider of intelligent industrial software solutions in China. According to the report by Zsight Consulting, with proprietary technology and independent intellectual property, they have created the industry's first and only full-stack intelligent manufacturing and operational management software solution. According to the same source of information, based on the industrial software revenue of advanced industries in 2024, the company is the largest Chinese provider of intelligent manufacturing software for advanced industries in the market. According to the same source of information, among the top ten Chinese intelligent manufacturing software companies ranked by revenue from advanced industries in 2024, they also have the fastest compound annual growth rate in revenue from 2022 to 2024.
Related Articles

AOM INT'L (00381) plans to issue 59 million Hong Kong dollars worth of convertible bonds to acquire a 72.5% stake in Jiangxi Jiu Ai Food Co., Ltd.

HAOHAI BIOTEC (06826) plans to acquire the remaining 20% equity interest of Shenzhen New Industries Biomedical Engineering Ophthalmic New Technology Co., Ltd. for 74 million yuan.

US Stock Market Move | Popular Chinese concept stocks generally fell, XPeng Inc. ADR Sponsored Class A (XPEV.US) dropped more than 6%.
AOM INT'L (00381) plans to issue 59 million Hong Kong dollars worth of convertible bonds to acquire a 72.5% stake in Jiangxi Jiu Ai Food Co., Ltd.

HAOHAI BIOTEC (06826) plans to acquire the remaining 20% equity interest of Shenzhen New Industries Biomedical Engineering Ophthalmic New Technology Co., Ltd. for 74 million yuan.

US Stock Market Move | Popular Chinese concept stocks generally fell, XPeng Inc. ADR Sponsored Class A (XPEV.US) dropped more than 6%.

RECOMMEND

Short Positions on Xiaomi (01810.HK) Surge 53% in a Week as Memory Price Spike Weighs on Sentiment
07/11/2025

Privatization Wave in Hong Kong Stocks: Exiting Liquidity Traps to Enable Strategic Transformation
07/11/2025

Over 30 Foreign Firms Attend Roundtable as Ministry of Commerce Signals Multiple Policy Shifts
07/11/2025


